Literature DB >> 15650216

Attenuating mutations of the matrix gene of influenza A/WSN/33 virus.

Teresa Liu1, Zhiping Ye.   

Abstract

The matrix protein (M1) of influenza virus plays an essential role in viral replication. Our previous studies have shown that basic amino acids 101RKLKR105 of M1 are involved in RNP binding and nuclear localization. For the present work, the functions of 101RKLKR105 were studied by introducing mutations into the M gene of influenza virus A/WSN/33 by reverse genetic methods. Individual substitution, R101S or R105S, had a minimal effect on viral replication. In contrast, the double mutation R101S-R105S was synergistic and resulted in temperature sensitivity reflected by reduced viral replication at a restrictive temperature. To investigate the in vivo effect on infection, BALB/c mice were infected with either A/WSN/33 wild-type (Wt) or mutant viruses and assessed for signs of illness, viral replication in the lungs, and survival rates. The results from mouse studies indicated that the R101S-R105S double mutant virus was strongly attenuated, while single mutant viruses R101S and R105S were minimally attenuated compared to A/WSN33 Wt under the same conditions. In challenge studies, mice immunized by infection with R101S-R105S were fully protected from lethal challenge with A/WSN/33. The replication and attenuating properties of R101S-R105S suggest its potential in development of live influenza virus vaccines.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15650216      PMCID: PMC544140          DOI: 10.1128/JVI.79.3.1918-1923.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  38 in total

1.  Four viral genes independently contribute to attenuation of live influenza A/Ann Arbor/6/60 (H2N2) cold-adapted reassortant virus vaccines.

Authors:  M H Snyder; R F Betts; D DeBorde; E L Tierney; M L Clements; D Herrington; S D Sears; R Dolin; H F Maassab; B R Murphy
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

2.  Transcription-inhibition and RNA-binding domains of influenza A virus matrix protein mapped with anti-idiotypic antibodies and synthetic peptides.

Authors:  Z P Ye; N W Baylor; R R Wagner
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

3.  Identification of sequence changes in the cold-adapted, live attenuated influenza vaccine strain, A/Ann Arbor/6/60 (H2N2).

Authors:  N J Cox; F Kitame; A P Kendal; H F Maassab; C Naeve
Journal:  Virology       Date:  1988-12       Impact factor: 3.616

4.  Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface.

Authors:  R A Lamb; S L Zebedee; C D Richardson
Journal:  Cell       Date:  1985-03       Impact factor: 41.582

Review 5.  The gene structure and replication of influenza virus.

Authors:  R A Lamb; P W Choppin
Journal:  Annu Rev Biochem       Date:  1983       Impact factor: 23.643

6.  Influenza virus, an RNA virus, synthesizes its messenger RNA in the nucleus of infected cells.

Authors:  C Herz; E Stavnezer; R Krug; T Gurney
Journal:  Cell       Date:  1981-11       Impact factor: 41.582

7.  Selective dansylation of M protein within intact influenza virions.

Authors:  B H Robertson; J C Bennett; R W Compans
Journal:  J Virol       Date:  1982-12       Impact factor: 5.103

8.  Association of influenza virus matrix protein with ribonucleoproteins.

Authors:  Z Ye; T Liu; D P Offringa; J McInnis; R A Levandowski
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

9.  Interaction of influenza M protein with viral lipid and phosphatidylcholine vesicles.

Authors:  A Gregoriades
Journal:  J Virol       Date:  1980-11       Impact factor: 5.103

10.  Functional and antigenic domains of the matrix (M1) protein of influenza A virus.

Authors:  Z P Ye; R Pal; J W Fox; R R Wagner
Journal:  J Virol       Date:  1987-02       Impact factor: 5.103

View more
  8 in total

1.  Mutations in influenza virus M1 CCHH, the putative zinc finger motif, cause attenuation in mice and protect mice against lethal influenza virus infection.

Authors:  Eric Ka-Wai Hui; Donald F Smee; Min-Hui Wong; Debi P Nayak
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

2.  The compensatory G88R change is essential in restoring the normal functions of influenza A/WSN/33 virus matrix protein 1 with a disrupted nuclear localization signal.

Authors:  Hang Xie; Zhengshi Lin; Philip D Mosier; Umesh R Desai; Yamei Gao
Journal:  J Virol       Date:  2012-10-17       Impact factor: 5.103

3.  Functional constraints of influenza A virus epitopes limit escape from cytotoxic T lymphocytes.

Authors:  E G M Berkhoff; E de Wit; M M Geelhoed-Mieras; A C M Boon; J Symons; R A M Fouchier; A D M E Osterhaus; G F Rimmelzwaan
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

4.  Influenza A virus inhibits alveolar fluid clearance in BALB/c mice.

Authors:  Kendra E Wolk; Eduardo R Lazarowski; Zachary P Traylor; Erin N Z Yu; Nancy A Jewell; Russell K Durbin; Joan E Durbin; Ian C Davis
Journal:  Am J Respir Crit Care Med       Date:  2008-08-08       Impact factor: 21.405

5.  Genetic contributions to influenza virus attenuation in the rat brain.

Authors:  Li Qi; Kathryn M Carbone; Zhiping Ye; Teresa Liu; Mikhail Ovanesov; Mikhail Pletnikov; Christian Sauder; Steven A Rubin
Journal:  J Neurovirol       Date:  2008-04       Impact factor: 2.643

6.  The M2 protein of live, attenuated influenza vaccine encodes a mutation that reduces replication in human nasal epithelial cells.

Authors:  Nicholas Wohlgemuth; Yang Ye; Katherine J Fenstermacher; Hsuan Liu; Andrew P Lane; Andrew Pekosz
Journal:  Vaccine       Date:  2017-10-25       Impact factor: 3.641

7.  Matrix protein 1: A comparative in silico study on different strains of influenza A H5N1 Virus.

Authors:  Tamanna Anwar; Sunil K Lal; Asad U Khan
Journal:  Bioinformation       Date:  2006-11-22

8.  Broad Spectrum Anti-Influenza Agents by Inhibiting Self-Association of Matrix Protein 1.

Authors:  Philip D Mosier; Meng-Jung Chiang; Zhengshi Lin; Yamei Gao; Bashayer Althufairi; Qibing Zhou; Faik Musayev; Martin K Safo; Hang Xie; Umesh R Desai
Journal:  Sci Rep       Date:  2016-08-30       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.